The Boston textbook publisher has acquired Visible Body, which specializes in making digital biomedical images for ...
The FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice regulations for active pharmaceutical ingredients.
Massachusetts. On Jan. 15, 2025, a warning letter was sent to Sanofi stating that FDA inspectors found irregularities with the facility's bioreactor, the vessel used to grow organisms and cells.
The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients at their ...
The governor argued the costs of services and doing business in Massachusetts are increasing and key sectors like health care, education, and housing are stressed under heightened demand from ...
20% of bioreactor runs at the Genzyme facility failed due to contamination or quality issues over 2.5 years. FDA identified 84 overdue deviation investigations, some exceeding 180 days ...
Senator Markey hosted a roundtable discussion that included Massachusetts’s Attorney General, who announced that her office is suing the Trump administration for targeting immigrants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback